Advertisement
Screener

Zhengye Biotechnology Holding Limited (ZYBT) Restricted Cash and Cash Equivalents

Zhengye Biotechnology Holding Limited Restricted Cash and Cash Equivalents

Zhengye Biotechnology Holding Limited (ZYBT) had Restricted Cash and Cash Equivalents of CNY 50.33 million as of 2025-12-31, per its 20-F filed 2026-04-28.

Financial Statements › Balance Sheet › Assets

us-gaap:RestrictedCashAndCashEquivalents · last filed 2026-04-28

  • 2025-12-31: Restricted Cash and Cash Equivalents 50.33M CNY.

CNY

Period endRestricted Cash and Cash Equivalents
2025-12-3150.33M CNY
20-F · filed 2026-04-28

USD

Period endRestricted Cash and Cash Equivalents
2025-12-31$7.20M
20-F · filed 2026-04-28